Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


McKesson Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

2026-02-07
It's been a pretty great week for McKesson Corporation ( NYSE:MCK ) shareholders, with its shares surging 14% to US$949...

I think the CEO of FedEx has done an incredible job, says Jim Cramer

2026-02-06
CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.

MCK Q3 Earnings & Sales Top Estimates, 2026 View Up

2026-02-06
McKesson beats Q3 EPS and revenue estimates, raises fiscal 2026 guidance, and delivers broad-based growth led by oncology, specialty distribution and technology.

US Stock Market Today: S&P 500 Futures Slip As Growth Jitters Offset Softer Yields

2026-02-06
The Morning Bull - US Market Morning Update Friday, Feb, 6 2026 US stock futures are slightly softer this morning, with E-mini S&P 500 contracts slipping about 0.1%, as investors weigh cooler US bond yields against mixed global growth signals. The US 10 year Treasury yield has dipped below 4.2% after several labor reports came in weaker than expected, which in plain terms means borrowing costs have eased a bit for households and businesses. At the same time, Germany’s exports reached €133.3b...

US Equity Markets Fall on Weak Jobs Data, Tech Slump

2026-02-05
US equity indexes fell Thursday as the labor market weakened, while tech stocks and cryptocurrencies

Equities Fall Intraday as Markets Assess Earnings, Macro Data Ahead of Amazon Results

2026-02-05
US benchmark equity indexes were lower intraday as traders parsed the latest batch of corporate earn

Stock Market Today, Feb. 5: S&P, Nasdaq fall after layoff data surprise; Alphabet details overspending

2026-02-05
This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Thursday. This is TheStreet’s Stock Market Today for Feb. 5, 2026. You can follow the latest updates on the market ...

Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right.

2026-02-05
Less than a month after raising its fiscal-year outlook, Cardinal Health hiked it again. The company, which distributes pharmaceuticals and other medical supplies to customers like CVS Health said Thursday that it now expects adjusted earnings in the range of $10.15 to $10.35 a share for the current fiscal year. The new range also is above the $10.02 a share analysts are expecting, according to FactSet.

McKesson Earnings Beat Highlights Oncology Growth And Medical Surgical Separation Plans

2026-02-05
McKesson (NYSE:MCK) reported a strong fiscal third quarter with double-digit growth in revenue and adjusted EPS. The company expanded its oncology, biopharma services, and North American pharmaceutical distribution operations during the quarter. Management raised full-year earnings guidance and highlighted progress toward separating the medical-surgical business, including transition service agreements. McKesson is preparing for a potential IPO of the medical-surgical unit while integrating...

McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?

2026-02-05
According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?